Development and validation of nomograms to provide individualized predictions of survival benefits from surgery in patients with intermediate/advanced hepatocellular carcinoma.Xin‐Fei Xu, Tian Yang, Hao Xing et al.|Journal of Clinical Oncology|2018Cited by 0